|
|
News Breaks
|
November 23, 2009
|
| 11:19 EDT |  | MDT |
| theflyonthewall.com: | Earnings Preview: Medtronic could report solid Q2 with core business stabilizing | | Medtronic (MDT) is expected to report Q2 earnings before the market opens on Tuesday, November 24 with a conference call scheduled for 8:00 am ET. Analysts are looking for a profit of 74c on revenue of $3.57B. The consensus range is 72c-77c for EPS, and revenue of $3.68B-$3.82B, according to First Call. Positive factors for this quarters results include a stabilization in the cardiac rhythm management business. Other positives for the quarter may come from stent sales, particularly from the company's popular Endeavor stent. In May, Medtronic said it expects FY10 revenue growth of 5%-8%. In early October, Piper Jaffray said that the the risk reward is favorable for Medtronic shares at current levels. Piper views Medtronic valuation as attractive and said concerns over healthcare reform are lessening. The firm said shares are Overweight rated. On November 5, Credit Suisse upgraded Medtronic and added it to its Focus List. The firm raised its target on shares to $49 from $41. Credit Suisse believes Medtronic's base business is stabilizing and the stock's risk/reward is compelling. :theflyonthewall.com |
|
|
News For MDT From The Last 14 Days Check below for free stories on MDT the last two weeks.
There are 11 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 11, 2012
|
| 12:53 EDT |  | MDT |
| theflyonthewall.com: | Medtronic seeks interest payment and royalties from NuVasive, Bloomberg says | | Medtronic (MDT) filed a request in San Diego federal court seeking payment from NuVasive (NUVA) for interest on a past jury verdict and royalty payments form patent infringements, reports Bloomberg. Reference Link :theflyonthewall.com |
|
|
February 8, 2012
|
| 08:02 EDT |  | MDT |
| theflyonthewall.com: | Medtronic stent led to 90% freedom from reinterventions at 12 months in study |
 Subscribe for More Information :theflyonthewall.com |
|
|
February 7, 2012
|
| 10:33 EDT |  | MDT |
| theflyonthewall.com: | Argus Research's healthcare analyst holds a conference call | | Senior Healthcare Analyst Toung discusses healthcare and growth ideas for 2012 on an Analyst/Industry conference call. Relevant covered companies ABC, ABT, AET, BAX, BDX, BSX, CAH, CHSI, CI, ESRX, HMA, HOLX, HUM, IART, JNJ, MCK, MDT, MHS, STJ, SYK, UNH and ZMH may be included on the Analyst/Industry conference call to be held on February 8 at 11 am. :theflyonthewall.com |
|
|
February 3, 2012
|
| 07:39 EDT | | MDT |
|
|
February 2, 2012
|
| 14:05 EDT | | MDT |
| theflyonthewall.com: | FDA and industry reach agreement in principle on medical device user fees | | The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com |
| | 12:15 EDT | | MDT |
| | 07:23 EDT | | MDT |
|
|
February 1, 2012
|
| 09:05 EDT | | MDT |
| | 08:00 EDT | | MDT |
|
|
January 30, 2012
|
| 17:15 EDT | | MDT |
| | 09:05 EDT | | MDT |
|
|
|
|
|
